🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of Labial Plate Thickness After Immediate Implant Placement Using Two Different Xenografts in the Esthetic Zone

RecruitingNAAges any - anyAllBasma Gamal Mohamed Ahmed
NCT07449806 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized clinical trial aims to evaluate labial bone plate changes following immediate implant placement in Type II extraction sockets using two different xenograft materials and de-epithelialized free gingival graft in the esthetic zone . Patients requiring extraction and immediate implant placement will be randomly allocated into two groups according to the xenograft material used for defect grafting. Clinical and radiographic outcomes will be assessed to determine dimensional bone changes and implant success

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with one or more non-restorable teeth or remaining roots without signs of acute infection in the maxillary anterior region. * Type II extraction sockets. * Sufficient bone (\>3 mm) apically and palatally to allow for proper implant positioning with sufficient primary stability (≥ 30 N cm). * Good compliance. Exclusion Criteria: * Teeth with current acute periapical infection. * Medically compromised patients. * Heavy smokers (smoking of more than 10 cigarettes per day ). * Alcohol or drug abuse. * Patients undergoing chemotherapy and radiotherapy. * Poor oral hygiene. * Vulnerable groups (pregnant females and decision- impaired individual).
💊

What it tests

  • Immediate Implant Placement with Medpark S1 xenograft
  • Immediate Implant Placement with bio-Oss xenograft
📍

Where

1 site
Faculty of Dentistry, Alexandria University, Egypt
Alexandria, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy